R Vitorino1, S-P Hojjat2,3, C G Cantrell4, A Feinstein5,6, L Zhang2, L Lee7,8, P O'Connor8, T J Carroll4,9, R I Aviv2,3. 1. Medical Imaging (R.V., S.-P.H., L.Z., R.I.A.), Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada rita.vitorino@sunnybrook.ca. 2. Medical Imaging (R.V., S.-P.H., L.Z., R.I.A.), Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada. 3. Medical Imaging (S.-P.H., R.I.A.), University of Toronto, Toronto, Ontario, Canada. 4. Departments of Biomedical Engineering (C.G.C., T.J.C). 5. From the Departments of Psychiatry (A.F.). 6. Psychiatry (A.F.). 7. Neurology (L.L.). 8. Departments of Medicine (L.L., P.O.). 9. Radiology (T.J.C.), Northwestern University, Chicago, Illinois.
Abstract
BACKGROUND AND PURPOSE: Cortical dysfunction, quantifiable by cerebral perfusion techniques, is prevalent in patients with MS, contributing to cognitive impairment. We sought to localize perfusion distribution differences in patients with relapsing-remitting MS with and without cognitive impairment and healthy controls. MATERIALS AND METHODS: Thirty-nine patients with relapsing-remitting MS (20 cognitively impaired, 19 nonimpaired) and 19 age- and sex-matched healthy controls underwent a neurocognitive battery and MR imaging. Voxel-based analysis compared regional deep and cortical GM perfusion and volume among the cohorts. RESULTS: After we adjusted for localized volumetric differences in the right frontal, temporal, and occipital lobes, progressive CBF and CBV deficits were present in the left middle frontal cortex for all cohorts and in the left superior frontal gyrus for patients with cognitive impairment compared with patients without impairment and controls. Compared with healthy controls, reduced CBF was present in the limbic regions of patients with cognitive impairment, and reduced CBV was present in the right middle frontal gyrus in patients with cognitive impairment and in the temporal gyrus of relapsing-remitting MS patients without cognitive impairment. CONCLUSIONS: Consistent regional frontal cortical perfusion deficits are present in patients with relapsing-remitting MS, with more widespread hypoperfusion in those with cognitive impairment, independent of structural differences, indicating that cortical perfusion may be a useful biomarker of cortical dysfunction and cognitive impairment in MS.
BACKGROUND AND PURPOSE:Cortical dysfunction, quantifiable by cerebral perfusion techniques, is prevalent in patients with MS, contributing to cognitive impairment. We sought to localize perfusion distribution differences in patients with relapsing-remitting MS with and without cognitive impairment and healthy controls. MATERIALS AND METHODS: Thirty-nine patients with relapsing-remitting MS (20 cognitively impaired, 19 nonimpaired) and 19 age- and sex-matched healthy controls underwent a neurocognitive battery and MR imaging. Voxel-based analysis compared regional deep and cortical GM perfusion and volume among the cohorts. RESULTS: After we adjusted for localized volumetric differences in the right frontal, temporal, and occipital lobes, progressive CBF and CBV deficits were present in the left middle frontal cortex for all cohorts and in the left superior frontal gyrus for patients with cognitive impairment compared with patients without impairment and controls. Compared with healthy controls, reduced CBF was present in the limbic regions of patients with cognitive impairment, and reduced CBV was present in the right middle frontal gyrus in patients with cognitive impairment and in the temporal gyrus of relapsing-remitting MS patients without cognitive impairment. CONCLUSIONS: Consistent regional frontal cortical perfusion deficits are present in patients with relapsing-remitting MS, with more widespread hypoperfusion in those with cognitive impairment, independent of structural differences, indicating that cortical perfusion may be a useful biomarker of cortical dysfunction and cognitive impairment in MS.
Authors: Ivana Nikić; Doron Merkler; Catherine Sorbara; Mary Brinkoetter; Mario Kreutzfeldt; Florence M Bareyre; Wolfgang Brück; Derron Bishop; Thomas Misgeld; Martin Kerschensteiner Journal: Nat Med Date: 2011-03-27 Impact factor: 53.440
Authors: Miguel D'haeseleer; Stéphanie Hostenbach; Ilse Peeters; Souraya El Sankari; Guy Nagels; Jacques De Keyser; Marie B D'hooghe Journal: J Cereb Blood Flow Metab Date: 2015-06-24 Impact factor: 6.200
Authors: Laëtitia Debernard; Tracy R Melzer; Saskia Van Stockum; Charlotte Graham; Claudia Am Wheeler-Kingshott; John C Dalrymple-Alford; David H Miller; Deborah F Mason Journal: J Neurol Neurosurg Psychiatry Date: 2013-09-13 Impact factor: 10.154
Authors: Mark Jenkinson; Christian F Beckmann; Timothy E J Behrens; Mark W Woolrich; Stephen M Smith Journal: Neuroimage Date: 2011-09-16 Impact factor: 6.556
Authors: W Rashid; L M Parkes; G T Ingle; D T Chard; A T Toosy; D R Altmann; M R Symms; P S Tofts; A J Thompson; D H Miller Journal: J Neurol Neurosurg Psychiatry Date: 2004-09 Impact factor: 10.154
Authors: Cristina Granziera; Jens Wuerfel; Frederik Barkhof; Massimiliano Calabrese; Nicola De Stefano; Christian Enzinger; Nikos Evangelou; Massimo Filippi; Jeroen J G Geurts; Daniel S Reich; Maria A Rocca; Stefan Ropele; Àlex Rovira; Pascal Sati; Ahmed T Toosy; Hugo Vrenken; Claudia A M Gandini Wheeler-Kingshott; Ludwig Kappos Journal: Brain Date: 2021-06-22 Impact factor: 13.501
Authors: Zafer Keser; Khader M Hasan; Benson Mwangi; Kyan Younes; Mahsa Khayat-Khoei; Arash Kamali; John A Lincoln; Flavia M Nelson Journal: Front Neurol Date: 2018-03-12 Impact factor: 4.003
Authors: Mar Jiménez de la Peña; Ignacio Casanova Peña; Pablo García-Polo García; Miguel López Gavilán; Norberto Malpica; Margarita Rubio; Rafael Arroyo González; Vicente Martínez de Vega Journal: Acta Radiol Open Date: 2019-12-30
Authors: Manuela Cerina; Venu Narayanan; Anna Delank; Patrick Meuth; Stephanie Graebenitz; Kerstin Göbel; Alexander M Herrmann; Stefanie Albrecht; Thiemo Daldrup; Thomas Seidenbecher; Ali Gorji; Tanja Kuhlmann; Heinz Wiendl; Christoph Kleinschnitz; Erwin J Speckmann; Hans-Christian Pape; Sven G Meuth; Thomas Budde Journal: Brain Struct Funct Date: 2018-05-09 Impact factor: 3.270